Vaccines

COVID-19

Breakthrough in mRNA Therapeutics: Sustainable Delivery Systems for Diverse Diseases

Researchers at Monash University have made significant strides in developing mRNA therapeutics for various diseases, driven by the success of mRNA vaccines for COVID-19. The team introduced a novel lipid-polymer hybrid nanoparticle design, leveraging medium-chain-length polyhydroxyalkanoates (mcl-PHAs) as a sustainable alternative to conventional poly(lactic-co-glycolic acid) (PLGA). By combining the